Searchable abstracts of presentations at key conferences in endocrinology

ea0032p760 | Obesity | ECE2013

Off-label GLP-1 agonist treatment in 43 non-diabetic patients: are weight loss and treatment tolerance equally promising outside of clinical trials?

Sauer Nina , Rohani Zaina , Wiesch Clarissa Schulze zur , Reining Franziska , Aberle Jens

Context: Recent data from controlled clinical trials have demonstrated that GLP-1 agonists are a well-tolerated therapy-option for weight loss in obese patients without type 2 diabetes mellitus.Objective: To investigate whether continuation of treatment, side-effects and effect on weight loss of GLP-1 agonists are equally promising in dairy clinical practice settings in non-diabetics.Methods: Obese, non-diabetic patients of our int...